Tag: Luminor DCB

Episode 1: Luminor DCB in the femoropopliteal segment: Outstanding safety and...

NOTE: This video is ONLY available to watch in selected countries and geographies Koen Deloose (Dendermonde, Belgium) moderates a three-part Vascular News series about the Luminor...

Episode 2: Experience of Luminor DCB in the below-the-knee segment

NOTE: This video is ONLY available to watch in selected countries and geographies Koen Deloose (Dendermonde, Belgium) moderates a three-part Vascular News series about the Luminor...

Episode 3: Not all DCBs are the same: Luminor TransferTech nanotechnology...

NOTE: This video is ONLY available to watch in selected countries and geographies  Koen Deloose (Dendermonde, Belgium) moderates a three-part Vascular News series about the Luminor...
Luminor

“No signal of increased risk of long-term mortality” with paclitaxel-coated Luminor...

An ad hoc, two-year analysis of the EffPac study found no signal of increased risk of long-term mortality, nor any adverse events, within two...

Luminor DCB now reimbursed in France

It was recently announced that luminor 18 and luminor 35 DCBs (iVascular), are now listed on the French LPPR list for de novo lesions...

Novel paclitaxel-nano-coated balloon achieves lower incidence of restenosis than plain balloon...

  Two-year results of EffPac—a randomised controlled trial to assess the safety and efficacy of a novel drug-coated balloon (DCB) with a nanotechnology coating—have been...

TINTIN trial shows “impressive” results at six months

The six-month results of TINTIN (Treatment with the lumINor DCB and The IVolutioN self-expanding stent) trial have been revealed at the annual meeting of the Cardiovascular and...

Enrolment complete in T.I.N.T.I.N. study

iVascular has announced the completion of enrolment of patients in its T.I.N.T.I.N. (Treatment with the Luminor DCB and the iVolution self-expanding stent) study. The effectiveness...